Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

Fig. 6

Overexpression of EZH2 reverses the inhibitory effect of CHD4 knockdown on the metastasis of ovarian cancer. A Cell viability of Skov3-ip-shControl, Skov3-ip-shCHD4, and Skov3-ip-shCHD4 + EZH2 OE cells. B, C Migration and invasion ability of Skov3-ip-shControl, Skov3-ip-shCHD4 and Skov3-ip-shCHD4 + EZH2 OE cells. Ruler: 200 μm. ***p < 0.0001, **p < 0.01

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us